What is Sinovac Biotech Price-to-Operating-Cash-Flow?
As of today (2024-04-25), Sinovac Biotech's share price is $6.47.
Sinovac Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.02. Hence, Sinovac Biotech's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Sinovac Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Sinovac Biotech's highest Price-to-Operating-Cash-Flow Ratio was 94.00. The lowest was 0.05. And the median was 18.17.
Sinovac Biotech's Cash Flow from Operations per share for the
six
months ended in Jun. 2023 was $-0.35.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.02.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sinovac Biotech was -100.00% per year.
During the past 13 years, Sinovac Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 933.50% per year. The lowest was -120.70% per year. And the median was 7.80% per year.
Sinovac Biotech Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Sinovac Biotech's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinovac Biotech Price-to-Operating-Cash-Flow Chart
|
Sinovac Biotech Annual Data
|
|
Trend |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
56.89 |
18.17 |
1.53 |
0.05 |
- |
|
Sinovac Biotech Semi-Annual Data
|
|
Dec13 |
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
2.04 |
0.05 |
- |
- |
- |
Competitive Comparison of Sinovac Biotech's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Sinovac Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinovac Biotech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sinovac Biotech's Price-to-Operating-Cash-Flow falls into.
Sinovac Biotech Price-to-Operating-Cash-Flow Calculation
Sinovac Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 6.47 | / | -0.022 |
| = | |
Sinovac Biotech's Share Price of today is $6.47.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinovac Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Sinovac Biotech (Sinovac Biotech) Business Description
Traded in Other Exchanges
N/A
Address
No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
Executives
| Lily Wang |
director, 10 percent owner, officer: Chief Financial Officer |
300 MURCHISON DR., MILLBRAE CA 94030 |
| Ifg Investments Services Inc |
10 percent owner |
PO BOX 822, CHARLESTOWN FEDERATION OF ST KITTS & NEVIS WEST INDIES P8 00000 |
| Yin Weidong |
director, 10 percent owner, officer: President and CEO |
|
| Terry G Bowering |
director, 10 percent owner, officer: President, CEO |
10 CEDAR MEADOW DRIVE REGINA A9 S4X 3J6 |
Sinovac Biotech (Sinovac Biotech) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SVA has been successfully added to your